All Posts

If you've ever felt judged at the doctor's office, this is the update you've been waiting for. How healthcare professionals talk about...

This question comes from one of the GLP-1 Newsroom readers. She wants to start back up on Ozempic after she gives birth, but can she take Ozempic while breastfeeding? I decided to do some digging and get all the information in one place to help other moms-to-be looking to rejoin their health program as soon as it is safe for momma and baby.

Maybe you’ve heard of Ozempic or Zepbound in passing—on the news, in a group chat, or from a coworker who “just isn’t hungry anymore.”...

You’ve probably heard the term metabolic syndrome tossed around lately—on wellness podcasts, in doctors’ offices, even on TikTok. It sounds serious (it is), but also vague (it kind of is). Is it diabetes? A slow metabolism? Is it just another name for being overweight? Not exactly. In this article, we'll explore what metabolic syndrome is, its risk factors

You can't turn a corner or scroll a social media site without seeing an ad or a post about someone taking GLP-1 meds like Ozempic or Wegovy. Most research shows one in eight people have tried them or is currently on them. Now, a new GLP-1 map shows a state-by-state breakdown of how many people are using these medications.

The way people eat is changing—and it’s not just another wellness trend. GLP-1 medications like Ozempic and Zepbound are rewriting the...

First, it was “Ozempic face”—that gaunt, hollowed look some people noticed after rapid weight loss on semaglutide. Then came the neck,...

In a major shake-up that’s bound to impact millions of patients, CVS Caremark is cutting ties with Eli Lilly’s weight loss drug Zepbound—and making Novo Nordisk’s Wegovy the go-to GLP-1 for obesity treatment. If your insurance runs through CVS Caremark, here’s what’s changing, why it’s happening, and what you should do next.

It turns out, sleep apnea is one of the many benefits science is exploring for GLP-1 agonists. While Zepbound got the first nod for OSA, there's a world of sleep standing between you and taking GLP-1s.

The landscape of diabetes and obesity management is on the cusp of a significant transformation, driven by the development of oral...

The World Health Organization (WHO) is getting ready to make a move that could reshape how the world handles obesity. For the first time,...

With demand for GLP-1 medications like semaglutide and tirzepatide soaring, clinical trials have quietly become one of the only ways some people can access treatment, especially if they’re uninsured or can’t afford retail prices. But before you go signing up for an experimental dose of the next Ozempic or peptide agonist, there are a few important things to understand. In this article, we'll talk about what clinical trials are, their pros and cons, what to expect, and how to

Retatrutide is being called the “triple threat” of weight loss drugs—and it’s not even on the market yet. Developed by Eli Lilly, the same pharmaceutical giant behind tirzepatide (better known as Mounjaro and Zepbound), this new contender is generating buzz for its potential to help people lose more weight, faster.

What I found was both wild and well-documented: the gut—yes, your gut—may be deeply involved in how osteoarthritis develops and how it could be treated. A hormone called GLP-1, best known for regulating digestion and appetite, might also protect cartilage and reduce joint inflammation. Researchers call it the gut-joint axis, and it’s changing the way we think about osteoarthritis.

If you're on a GLP-1 diet—whether it’s Ozempic, Wegovy, Mounjaro, Zepbound, or any of the others—you’ve probably heard some chatter about magnesium. But before you grab just any bottle off the shelf, there’s something you should know: not all magnesium supplements are created equal. Picking the wrong type can make your symptoms worse—or just do nothing at all.

The window for GLP-1 compounders to tap dance around the compounding ban is almost closed — and anyone still trying to squeeze through could end up with some bruised fingers. A federal court ruling has backed the FDA’s determination that shortages of Wegovy and Ozempic are officially over, setting up a sharp end to the era of legally available compounded GLP-1s.

File it under "you know someone is true friend when," category, but when the infamous sulphur burps of a GLP-1 diet hit me, I had to know...

Starting a GLP-1 journey can feel overwhelming — not just because of the medication, but because of the new language that comes with it....

Women make up the majority of GLP-1 users, meaning they take medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro,...

GLP-1 medications are poised to be a $125 billion industry by 2030, and that has a lot of people wondering how to get the same boost you can get in drugs like Ozempic and Zepbound naturally.